Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thorsten Hage
Observed names:
Hage, Thorsten,
T. Hage
Institution:
BioCrea (Germany)
Observed institutions:
University of Würzburg,
BioCrea (Germany)
OpenAlex ID:
A5110100245
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
2009
·
Steven M. Grauer
, Virginia L. Pulito
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
289
Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface
1999
·
Thorsten Hage
, Walter Sebald
, et al.
·
Cell
·
244
PDF
Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801
2012
·
Olga A.H. Reneerkens
, Kris Rutten
, et al.
·
Behavioural Brain Research
·
98
Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction: A Biosensor Study Employing Recombinant Interleukin‐4‐Binding Protein
1996
·
Bo‐Jiang Shen
, Thorsten Hage
, et al.
·
European Journal of Biochemistry
·
92
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors
2011
·
Michael S. Malamas
, Yike Ni
, et al.
·
Journal of Medicinal Chemistry
·
79
Discovery of Imidazo[1,5-a]pyrido[3,2-e]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors
2010
·
Norbert Höfgen
, Hans Stange
, et al.
·
Journal of Medicinal Chemistry
·
68
Novel triazines as potent and selective phosphodiesterase 10A inhibitors
2012
·
Michael S. Malamas
, Hans Stange
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
Phosphodiesterase 2 Inhibitors Promote Axonal Outgrowth in Organotypic Slice Co-Cultures
2012
·
C. Heine
, K. Sygnecka
, et al.
·
Neurosignals
·
17
Crystals of a 1 : 1 complex between human interleukin‐4 and the extracellular domain of its receptor α chain
1998
·
Thorsten Hage
, Peter Reinemer
, et al.
·
European Journal of Biochemistry
·
11
PDF
RNA-Based Drug Screening Using Automated RNA Purification and Real-time RT-PCR1
2004
·
Susanne Ullmann
, Thorsten Hage
, et al.
·
SLAS DISCOVERY
·
5
P.1.g.012 The pro-cognitive profile of the phosphodiesterase 2A inhibitor BCR909 highlights its utility as a novel treatment for diseases with cognitive decline
2011
·
B. Langen
, R. Dost
, et al.
·
European Neuropsychopharmacology
·
1
Inhibitors of the phosphodiesterase 2 increased axonal fibre growth in a dopaminergic organotypic ex vivo slice co-culture model
2011
·
Claudia Heine
, Nico Scherf
, et al.
·
BMC Pharmacology
·
1
P.1.c.021 Effect of phosphodiesterase 2A inhibition on striatal dopamine in a microdialysis study and its reflection in dopamine-associated effects in animal models
2011
·
B. Langen
, R. Dost
, et al.
·
European Neuropsychopharmacology
P.3.d.005 Activity of phosphodiesterase 10A inhibitors in a novel animal model of negative symptoms of schizophrenia
2010
·
B. Langen
, D. Zschaber
, et al.
·
European Neuropsychopharmacology
P.2.d.002 The phosphodiesterase 2 inhibitor BTT5001 demonstrates anxiolytic, anti-depressive and pro-cognitive efficacy in vivo
2009
·
B. Langen
, T. Hage
, et al.
·
European Neuropsychopharmacology
Pde10 Inhibition for the Treatment of Schizophrenia
2008
·
Nicholas J. Brandon
, Mike Malamas
, et al.
·
Schizophrenia Research
Show more works
View as search
Works count:
20
Citation count:
931
H-index:
9
I10-index:
9
Year
Topic
Type